Letter from the President.
Quarterly perspective from GAP's leadership on the breakthroughs, partnerships, and people defining the future of brain health — delivered to your inbox.
GAP’s 2026 Q2 Highlights
Colleagues, Partners & Friends, As we look forward to seeing many of you at the 2026 Alzheimer’s Association International Conference in London, I look back with pride on the Global Alzheimer’s Platform Foundation’s (GAP) Q2 performance. Our Trial Execution Services (TES) (GAP Participant Services and Inclusive Research Initiative®) teams collectively supported 120 GAP-Net site events […]
GAP’s 2026 Q1 Highlights
Colleagues, Trusted Partners, & Friends, We want to share a brief update on how Q1 of 2026 unfolded for the Global Alzheimer’s Platform Foundation (GAP) and the significant work anticipated ahead. In January, our work received global coverage as the British Broadcasting Corporation (BBC) spotlighted the Bio-Hermes-002 (BH2) study in a story about a finger prick blood test […]
GAP’s 2025 IRI Virtual Conference
Last week, the Global Alzheimer’s Platform Foundation’s (GAP) Inclusive Research Initiative (IRI) team hosted its second annual virtual conference focused on improving Alzheimer’s and dementia research by increasing diversity among participants in neurodegenerative clinical trials. We are proud to have created a platform for meaningful dialogue and hope it has inspired new ideas, collaborations, and opportunities for those […]